I’m Finally Practicing Medicine the Way It Should Be Done
In medical school, I planned to be a primary care doctor. I started residency at a Harvard teaching…
Medline’s Blockbuster IPO–And Its Billionaire Founding Family
In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes’ inaugural top hospitals…
Plans to charge some Jersey A&E patients put on hold
Plans to charge patients for using Jersey’s only A&E department for non-urgent treatment have been put on hold.…
5 biomarkers that can predict your lifespan
Longevity specialist says that testing five simple biomarkers can reveal how long – and how well – you…
Unite and Untie Healthcare – CounterPunch.org
Photograph Source: Marc Nozell from Merrimack, New Hampshire, USA – CC BY 2.0 We all know the story.…
Meet the 2026 AHCJ U.S. and International fellows
From left to right, top row: Anna Vollers, Sofia Resnick, Shalina Chatlani, Kelcie Moseley-Morris, Nada Hassanein. Second row…
Are CDC Data Still Accurate? Why They Remain Trustworthy
Back in February (a lifetime ago), when data were being edited under Executive Orders and all CDC communications…
How Data Is Shaping Vaginal Microbiome and UTI Care
Evvy’s At Home UTI Diagnostic Kit Evvy uses advanced microbiome and PCR diagnostics to improve care for BV,…
Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study
Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced…
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce…
US health officials re-examine RSV shots despite documented safety and efficacy | Trump administration
US regulatory officials are re-examining the safety of RSV shots despite no published reports of safety issues –…
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…